Nanobac Pharmaceuticals Income Statement
View: Annual
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 0.0 | 0.2 | 0.7 |
| Cost of Goods Sold | 0.0 | 0.1 | 0.2 |
| Gross Profit | 0.0 | 0.2 | 0.4 |
| Gross Profit Margin | 50.0% | 65.2% | 65.2% |
| SG&A Expense | 4.5 | 4.4 | 2.5 |
| Depreciation & Amortization | 0.5 | 0.5 | 0.8 |
| Operating Income | (4.9) | (4.8) | (2.8) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | (1.5) | 0.0 | (0.8) |
| Nonoperating Expenses | 0.2 | 0.2 | 0.1 |
| Income Before Taxes | (6.6) | (5.0) | (3.7) |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | (6.6) | (5.0) | (3.7) |
| Continuing Operations | (6.6) | (5.0) | (3.7) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (6.6) | (5.0) | (3.7) |
| Total Net Income | (6.6) | (5.0) | (3.7) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.03) | (0.02) | (0.02) |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
